Operating signal within 12 months from two or more independent sources.
What they make
In-Vitro Diagnostic Substance Manufacturing325413Baebies manufactures the FINDER multifunctional diagnostic platform, which performs molecular, immunoassay, coagulation, and chemistry tests using digital microfluidics technology for rapid near-patient testing. The company offers specific tests including a G6PD test, a Flu A/B and SARS-CoV-2 test, and an Anti-Factor Xa test. The FINDER Flu A/B and SARS-CoV-2 test is U.S. FDA 510(k) cleared and CLIA waived, the G6PD test is CE-marked and U.S. FDA cleared, and the Anti-Factor Xa test received U.S. FDA Breakthrough Device Designation.
SUMMARIZED FROM THE COMPANY’S OWN WEBSITE
Products
Where these came from
Where it is
Location not verified — this address could not be matched to Census TIGER, so the facility is not placed on the map.
Other plants nearby
No other listed facility within 40 km shares this one’s four-digit industry code, or this record has no coordinates to measure from.
Also at this address
No other federal record shares this street address.
WHERE THIS RECORD COMES FROM — 3 FEDERAL SOURCES, 7 FIELDS
Every fact on this page traces to a public federal filing. The table below names which register holds this facility, whether that register proves the plant operates or only that it exists, and when each of them last saw it.
| Source | Evidence | First seen | Last seen |
|---|---|---|---|
| FDA DEVICES | OPERATING | AUG 2026 | AUG 2026 |
| COMPANY SITE | OPERATING | JUL 2026 | AUG 2026 |
| SAM GOV | OPERATING | MAY 2026 | MAY 2026 |
FIELD BY FIELD — WHICH SOURCE SUPPLIED WHAT
| FIELD | SOURCE | SIGNAL |
|---|---|---|
| ADDRESS LINE1 | SAM GOV | MAY 2026 |
| CAGE CODE | SAM GOV | MAY 2026 |
| CITY | SAM GOV | MAY 2026 |
| NAME | SAM GOV | MAY 2026 |
| REGISTRATION EXPIRATION | SAM GOV | MAY 2026 |
| STATE | SAM GOV | MAY 2026 |
| WEBSITE | SAM GOV | MAY 2026 |
Status is computed from independent sources; nothing here is self-reported unless marked Claimed.